BioCatalyst

Sonelokimab, Risankizumab — catalyst calendar

1 verified catalyst event(s) referencing Sonelokimab, Risankizumab, each linked to its official source. Verified as of 2026-10-01.

Upcoming

DateEventCompanyDrugOfficial source & verification
2027-01-15
in 4mo
ESTIMATED
 READOUT
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-T
Phase 3 · Arthritis, Psoriatic
 MLTX MoonLake Immunotherapeutics Sonelokimab, Risankizumab ClinicalTrials.gov ↗
✓ Source-checked 2026-10-01
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.